044cbef6cafb4f6885cbbed997f99eca0a99834366c3406a86be7f7e614d9f0c149e6c2f944f428f9891aa9cd22568021eb198d9305d47168781a78224a8e3313f5e7cac2a084ecfa8efb5f87154b74845e8666b38b84d118fa674cb2cb31f63474ea60d496d4e6fb7fd245063e3f9798233357be1a84b5da168efc558a142b882757ea660444f5e9a2fef372ab0a3b88add40bd1327405aa09588d15aca7ad49dcec8f6615a49e5a24313d0f0c3256cc77b431cb5aa4c668df234f68e897564
agent
Natural killer cells in multiple sclerosisNK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosisProportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patientsStress-Axis Regulation by Vitamin D-3 in Multiple SclerosisConsiderations on vitamin D supplementation in multiple sclerosisHypercalcaemia rather than high dose vitamin D3 supplements could exacerbate multiple sclerosisThe Engagement Between Vitamin D and the Immune SystemNetwork of nuclear receptor ligands in multiple sclerosisPrognostic value of NK cell/ T cell ratios for disease activity in multiple sclerosisVitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosisVitamin D3 supplementation and neurofilament light chain in multiple sclerosisCirculating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis
author
nationality
type
label
Jan Damoiseaux
firstName
lastName
Damoiseaux